Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03199586
Title Phase 1 Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Solid Tumors (Including Lymphoma)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novita Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Research Institute Scottsdale Arizona 85258 United States Details
City of Hope National Medical Center Duarte California 91010 United States Details
Memorial Sloan Kettering Hospital New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field